Your browser doesn't support javascript.
loading
Publisher Correction: The long tail of oncogenic drivers in prostate cancer.
Armenia, Joshua; Wankowicz, Stephanie A M; Liu, David; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K; Chakravarty, Debyani; Han, G Celine; Coleman, Ilsa; Montgomery, Bruce; Pritchard, Colin; Morrissey, Colm; Barbieri, Christopher E; Beltran, Himisha; Sboner, Andrea; Zafeiriou, Zafeiris; Miranda, Susana; Bielski, Craig M; Penson, Alexander V; Tolonen, Charlotte; Huang, Franklin W; Robinson, Dan; Wu, Yi Mi; Lonigro, Robert; Garraway, Levi A; Demichelis, Francesca; Kantoff, Philip W; Taplin, Mary-Ellen; Abida, Wassim; Taylor, Barry S; Scher, Howard I; Nelson, Peter S; de Bono, Johann S; Rubin, Mark A; Sawyers, Charles L; Chinnaiyan, Arul M; Schultz, Nikolaus; Van Allen, Eliezer M.
Affiliation
  • Armenia J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wankowicz SAM; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gao J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kundra R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Reznik E; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Chatila WK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chakravarty D; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Han GC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Coleman I; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Montgomery B; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pritchard C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morrissey C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Barbieri CE; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Beltran H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sboner A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zafeiriou Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Miranda S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bielski CM; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Penson AV; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Tolonen C; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Huang FW; Department of Urology, University of Washington, Seattle, WA, USA.
  • Robinson D; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Wu YM; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Lonigro R; Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.
  • Garraway LA; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.
  • Demichelis F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Kantoff PW; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.
  • Taplin ME; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.
  • Abida W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Taylor BS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Scher HI; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nelson PS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • de Bono JS; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Rubin MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sawyers CL; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Schultz N; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Genet ; 51(7): 1194, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31152158
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: Country of publication: